InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Clark Julie, Directeur Médical. Director active across 1 companies, notably Adverum Biotechnologies, Inc.. Cumulatively, 4 disclosures have been recorded. Total volume traded: €18k. The latest transaction was filed on 30 September 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€8,9354,766 shares@ €1.8748100.0% of flow
Common Stock
SEC:0001209191-21-059094·
€8,9354,766 shares@ €1.874850.0% of flow
Common Stock
SEC:0001209191-21-059094:0·
0120,000 shares0
Common Stock
SEC:0001209191-21-050750·
0120,000 shares0
Common Stock
SEC:0001209191-21-050750:0·
4 of 4 declarations
About Clark Julie
Clark Julie serves as Chief Medical Officer at Adverum Biotechnologies, Inc. She is responsible for the company's medical affairs and clinical research. Her expertise is crucial for supporting the development of new treatments and therapies.
